Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Carilex MedicalROCO:7726 33 PB Ratio is 2.24 as of Jul. 31, 2026, which is 10% below its 10-year median of 2.49. GuruFocus rates ROCO:7726 with a GF Score™ of 33/100. The stock has 5 warning signs investors should review. Among 787 Medical Devices & Instruments companies, Carilex Medical ranks worse than 54.38% on this metric.
The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. As of today (2026-07-31), Carilex Medical's share price is NT$32.15. Carilex Medical's Book Value per Share for the quarter that ended in Dec. 2025 was NT$14.33. Hence, Carilex Medical's PB Ratio of today is 2.24.
Good Sign:
Carilex Medical Inc stock PB Ratio (=2.23) is close to 3-year low of 2.01.
The historical rank and industry rank for Carilex Medical's PB Ratio or its related term are showing as below:
ROCO:7726'
s PB Ratio Range Over the Past 10 Years
Min: 2.01 Med: 2.49 Max: 3.95
Current: 2.24
During the past 6 years, Carilex Medical's highest PB Ratio was 3.95. The lowest was 2.01. And the median was 2.49.
ROCO:7726's PB Ratio is ranked worse than 54.38% of 787
companies
in the Medical Devices & Instruments industry
Industry Median: 2.05
vs ROCO:7726: 2.24
During the past 12 months, Carilex Medical's average Book Value Per Share Growth Rate was -11.80% per year.
During the past 3 years, the average Book Value Per Share Growth Rate was 7.00% per year.
During the past 5 years, the average Book Value Per Share Growth Rate was 10.00% per year.
During the past 6 years, the highest 3-Year average Book Value Per Share Growth Rate of Carilex Medical was 17.60% per year. The lowest was 7.00% per year. And the median was 17.50% per year.
The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.
Be Aware
Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.
Carilex Medical PB Ratio Related Terms
Carilex Medical PB Ratio Historical Data
* Premium members only.
The historical data trend for Carilex Medical's PB Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Devices subindustry, Carilex Medical's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Carilex Medical PB Ratio vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Carilex Medical's PB Ratio distribution charts can be found below:
* The bar in red indicates where Carilex Medical's PB Ratio falls into.
The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.
Carilex Medical's PB Ratio for today is calculated as follows:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.
Carilex Medical (ROCO:7726) has a PB Ratio of 2.24 as of Jul. 31, 2026. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on Carilex Medical and its competitors. This is 10% below median its historical median of 2.49. Over the past decade, Carilex Medical's PB Ratio has ranged from 2.01 to 3.95. According to the industry distribution chart, Carilex Medical ranks #428 out of 787 companies in the Medical Devices & Instruments industry, placing it in the top 54.4%.
Is Carilex Medical's PB Ratio too high?
Carilex Medical's current PB Ratio of 2.24 is 10% below median its 10-year median of 2.49. Over the past 10 years, this metric has ranged from a low of 2.01 to a high of 3.95. The Medical Devices & Instruments industry median PB Ratio is 2.05. Carilex Medical's value of 2.24 is 9.3% above this industry median. Based on the distribution chart, Carilex Medical ranks #428 out of 787 companies in the Medical Devices & Instruments industry, which is below the industry midpoint. Overall, Carilex Medical has a GF Score™ of 33/100, reflecting its overall financial health beyond just this single metric.
How does Carilex Medical's PB Ratio compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Carilex Medical ranks #428 out of 787 companies for PB Ratio. This places Carilex Medical in the lower half of its industry. The industry median PB Ratio is 2.05. Carilex Medical's value of 2.24 is 9.3% above this benchmark. Historically, Carilex Medical's own PB Ratio has ranged from 2.01 to 3.95 over the past decade. While the company's 10-year median is 2.49 vs. the industry median of 2.05, Carilex Medical has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PB Ratio for a Medical Devices & Instruments company?
The median PB Ratio among Medical Devices & Instruments companies is 2.05, based on 787 companies in the industry. Companies in the top quartile (top 25%) have a PB Ratio significantly above this median, while those in the bottom quartile fall well below. However, PB Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Carilex Medical's current PB Ratio of 2.24 is 9.3% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PB Ratio mean?
A high PB Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on Carilex Medical and its competitors. For the Medical Devices & Instruments industry, the median PB Ratio is 2.05 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Carilex Medical's current PB Ratio is 2.24, which is 10% below median its own 10-year median of 2.49. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Carilex Medical stock overvalued right now?
Carilex Medical (ROCO:7726) has a current PB Ratio of 2.24. The current PB Ratio is 2.24, which is 10% below median its 10-year median of 2.49 and 9.3% above the Medical Devices & Instruments industry median of 2.05. Carilex Medical's overall GF Score™ is 33/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PB Ratio calculated?
PB Ratio is calculated from a company's financial statements. For Carilex Medical (ROCO:7726), the current PB Ratio is 2.24 as of Jul. 31, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Carilex Medical Inc is a company engaged in the wound care industry by developing leading-edge technology in the prevention and treatment of wounds. Their expertise is in research and development, manufacturing, and quality control and assurance allow us to provide unparalleled products in wound care management in the form of comprehensive product lines proven to prevent and manage pressure sores and wounds. They offer products in the form of Support Surfaces, Chair Cushion and Negative Pressure Wound Therapy.
33GF Score
Get the complete analysis for ROCO:7726
PB Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ROCO:7726 has been successfully added to your 
